Cargando…

Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening

[Image: see text] C-C chemokine receptor type 5 (CCR5) is a member of the G protein-coupled receptor. CCR5 and its interaction with chemokine ligands have been crucial for understanding and tackling human immunodeficiency virus (HIV)-1 entry into target cells. In recent years, the change in CCR5 exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Zohairy, Mariam A., Zlotos, Darius P., Berger, Martin R., Adwan, Hassan H., Mandour, Yasmine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153923/ https://www.ncbi.nlm.nih.gov/pubmed/34056245 http://dx.doi.org/10.1021/acsomega.1c00681

Ejemplares similares

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
por: Bocci, G, et al.
Publicado: (2008)

Ginger as an anticolorectal cancer spice: A systematic review of in vitro to clinical evidence
por: Nachvak, Seyed Mostafa, et al.
Publicado: (2022)

Anticolorectal Cancer Effects of AUCAN: Effects to Suppress Proliferation, Metastasis, and Invasion of Tumor Cells
por: Xiong, Liu-Lin, et al.
Publicado: (2020)

Establishment of In Vitro and In Vivo Anticolorectal Cancer Efficacy of Lithocholic Acid-Based Imidazolium Salts
por: Sawicka, Diana, et al.
Publicado: (2022)

Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands
por: Zlotos, Darius P., et al.
Publicado: (2022)

Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7
por: Mandour, Yasmine M, et al.
Publicado: (2018)

GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment
por: Du, Yang, et al.
Publicado: (2015)

Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity
por: Wang, Jigang, et al.
Publicado: (2017)

Virtual Screening of Chemical Compounds for Discovery of Complement C3 Ligands
por: Mohan, Rohith R., et al.
Publicado: (2018)

Discovery of High-Affinity Amyloid Ligands Using a Ligand-Based Virtual Screening Pipeline
por: Chisholm, Timothy S., et al.
Publicado: (2023)

Virtual Screening and Biological Evaluation of Potential PD-1/PD-L1 Immune Checkpoint Inhibitors as Anti-Hepatocellular Carcinoma Agents
por: Kamal, Monica A., et al.
Publicado: (2023)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays
por: Zhou, Wenfang, et al.
Publicado: (2018)

Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis
por: Pervaiz, Asim, et al.
Publicado: (2020)

Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques
por: Noha, Stefan M., et al.
Publicado: (2011)

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

When drug discovery meets web search: Learning to Rank for ligand-based virtual screening
por: Zhang, Wei, et al.
Publicado: (2015)

Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors
por: Al-Sanea, Mohammad M., et al.
Publicado: (2022)

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches
por: Vázquez, Javier, et al.
Publicado: (2020)

Lead Discovery Using Virtual Screening
por: Bikker, Jack Andrew, et al.
Publicado: (2009)

Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents
por: Li, Bing-Hui, et al.
Publicado: (2021)

Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
por: Stein, Reed M., et al.
Publicado: (2020)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020)

Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3
por: Shao, Zhehua, et al.
Publicado: (2022)

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors
por: Vuorinen, Anna, et al.
Publicado: (2014)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

Virtual ligand screening: strategies, perspectives and limitations
por: Klebe, Gerhard
Publicado: (2006)

Virtual Screening in Lead Discovery: A Viewpoint†
por: Oprea, Tudor Ionel
Publicado: (2002)

Virtual screening for the discovery of bioactive natural products
por: Rollinger, Judith M., et al.
Publicado: (2008)

Modeling of human CCR5 as Target for HIV-I and Virtual Screening with Marine Therapeutic compounds
por: Manikandan, Selvaraj, et al.
Publicado: (2008)

Discovery of Akt Kinase Inhibitors through Structure-Based Virtual Screening and Their Evaluation as Potential Anticancer Agents
por: Chuang, Chih-Hung, et al.
Publicado: (2015)

Crystal structure of 5,11-dihydropyrido[2,3-b][1,4]benzodiazepin-6-one
por: Riad, Noura M., et al.
Publicado: (2015)

Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis
por: Georges, Rania, et al.
Publicado: (2012)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
por: Korbecki, Jan, et al.
Publicado: (2020)

Discovery of Potential Chemical Probe as Inhibitors of CXCL12 Using Ligand-Based Virtual Screening and Molecular Dynamic Simulation
por: Haider, Sajjad, et al.
Publicado: (2020)

New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]- ethyl}acetamide: a contaminant in commercial melatonin preparations
por: Darwish, Hany W., et al.
Publicado: (2012)

Erratum to: New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]-ethyl}acetamide: a contaminant in commercial melatonin preparations
por: Darwish, Hany W., et al.
Publicado: (2016)

Sequential ligand- and structure-based virtual screening approach for the identification of potential G protein-coupled estrogen receptor-1 (GPER-1) modulators
por: Khan, Shafi Ullah, et al.
Publicado: (2019)

Optimal assignment methods for ligand-based virtual screening
por: Jahn, Andreas, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j75s1mdj1feae7034ipe5on9de